Known targets — ChEMBL curated mechanism
PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.95 |
| ▸ | ARG2 | P78540 | 4/20 | 0.61 |
| ▸ | ARG1 | P05089 | 3/20 | 0.57 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.56 |
| ▸ | NOS2 | P35228 | 4/20 | 0.53 |
| ▸ | NOS1 | P29475 | 3/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | NOS3 | P29474 | 2/20 | 0.50 |
| ▸ | GGT1 | P19440 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | GRM8 | O00222 | 1/20 | 0.50 |
| ▸ | GRM6 | O15303 | 1/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.50 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 1/20 | 0.50 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.50 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lysine SCHEMBL875015 | 1.00 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL706905 | 1.00 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL8029574 | 1.00 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL41761 | 1.00 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL1191963 | 1.00 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL10582149 | 1.00 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL9762590 | 1.00 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL41760 | 1.00 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL2478576 | 1.00 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 | |
| Lysine SCHEMBL30928253 | 1.00 | GSR (0.95) | GSRARG2ARG1RNPEPNOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250011344-A1 | PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF | TERRAN BIOSCIENCES INC (US) | 2025-01-09 | — | — | US | disclosed |
| US-20240335592-A1 | NANOCRYSTALLINE HYDROXYAPATITE/POLYURETHANE HYBRID POLYMERS AND SYNTHESIS THEREOF | VANDERBILT UNIVERSITY | 2024-10-10 | — | — | US | disclosed |
| EP-4387608-A1 | PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF | Terran Biosciences, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| CN-118119389-A | Prodrugs and derivatives of des-phosphate nupharicin and uses thereof | 人类生物科学股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-117956991-A | N, N-dimethyltryptamine and related hallucinogens and uses thereof | 人类生物科学股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-11866408-B2 | N,N-dimethyltryptamine and related psychedelics and uses thereof | TERRAN BIOSCIENCES INC. (US) | 2024-01-09 | — | — | US | disclosed |
| US-20230212119-A1 | N,N-DIMETHYLTRYPTAMINE AND RELATED PSYCHEDELICS AND USES THEREOF | TERRAN BIOSCIENCES INC. | 2023-07-06 | — | — | US | disclosed |
| WO-2023023347-A1 | PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF | TERRAN BIOSCIENCES INC. (US) | 2023-02-23 | — | — | WO | disclosed |
| US-20220409772-A1 | NANOCRYSTALLINE HYDROXYAPATITE/POLYURETHANE HYBRID POLYMERS AND SYNTHESIS THEREOF | VANDERBILT UNIVERSITY | 2022-12-29 | — | — | US | disclosed |
| US-20180311413-A1 | NANOCRYSTALLINE HYDROXYAPATITE/POLYURETHANE HYBRID POLYMERS AND SYNTHESIS THEREOF | VANDERBILT UNIVERSITY | 2018-11-01 | — | — | US | disclosed |
| EP-3362572-A1 | NANOCRYSTALLINE HYDROXYAPATITE/POLYURETHANE HYBRID POLYMERS AND SYNTHESIS THEREOF | Vanderbilt University (US) | 2018-08-22 | — | — | EP | disclosed |
| US-20170121278-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | WARSAW ORTHOPEDIC INC (US) | 2017-05-04 | — | — | US | disclosed |
| WO-2017066807-A1 | NANOCRYSTALLINE HYDROXYAPATITE/POLYURETHANE HYBRID POLYMERS AND SYNTHESIS THEREOF | VANDERBILT UNIVERSITY (US) | 2017-04-20 | — | — | WO | disclosed |
| US-9573889-B2 | Methods and compositions for making an amino acid triisocyanate | WARSAW ORTHOPEDIC, INC. (US) | 2017-02-21 | — | — | US | disclosed |
| US-20160168085-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | WARSAW ORTHOPEDIC INC (US) | 2016-06-16 | — | — | US | disclosed |
| US-9266824-B2 | Methods and compositions for making an amino acid triisocyanate | WARSAW ORTHOPEDIC, INC. (US) | 2016-02-23 | — | — | US | disclosed |
| US-20150197483-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIHYDROCHLORIDE | WARSAW ORTHOPEDIC, INC. (US) | 2015-07-16 | — | — | US | disclosed |
| US-20150197488-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | WARSAW ORTHOPEDIC, INC. (US) | 2015-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170121278-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | AADAT, AGT, PHYKPL | GSR 3482/4885ARG2 1485/4885ARG1 571/4885 |
| US-20150197483-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIHYDROCHLORIDE | ALKBH3, AADAT, ALKBH1 | GSR 4740/4885ARG2 198/4885ARG1 87/4885 |
| US-20150197488-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | AADAT, AGT, PHYKPL | GSR 3482/4885ARG2 1485/4885ARG1 571/4885 |
| US-20230212119-A1 | N,N-DIMETHYLTRYPTAMINE AND RELATED PSYCHEDELICS AND USES THEREOF | PNMT, HTR5A, HNMT | GSR 2549/4885ARG2 3127/4885ARG1 3446/4885 |
| US-20160168085-A1 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE | AADAT, AGT, PHYKPL | GSR 3482/4885ARG2 1485/4885ARG1 571/4885 |
| US-20250011344-A1 | PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF | PSAP, PIGO, PSAT1 | GSR 288/4885ARG2 3013/4885ARG1 4591/4885 |
| US-11866408-B2 | N,N-dimethyltryptamine and related psychedelics and uses thereof | PNMT, HTR5A, HNMT | GSR 2549/4885ARG2 3127/4885ARG1 3446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.